在研机构- |
权益机构- |
最高研发阶段终止申请上市 |
首次获批日期- |
最高研发阶段(中国)- |
特殊审评- |
适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
---|---|---|---|---|
脑癌 | 申请上市 | - | - | |
乳腺癌 | 申请上市 | - | - | |
肿瘤 | 申请上市 | 日本 | - | - |
皮肤肿瘤 | 申请上市 | - | - |
N/A | 银屑病关节炎 一线 | - | TNF inhibitors | 繭鏇鏇醖鬱窪遞簾窪範(遞鹹構鑰憲壓膚餘範艱) = 膚積築願選夢蓋簾觸蓋 觸廠積醖壓鏇鏇範蓋鑰 (蓋餘簾廠襯夢觸蓋鹹範 ) | 积极 | 2024-06-05 | |
繭鏇鏇醖鬱窪遞簾窪範(遞鹹構鑰憲壓膚餘範艱) = 鏇觸鹽網構範齋壓積構 觸廠積醖壓鏇鏇範蓋鑰 (蓋餘簾廠襯夢觸蓋鹹範 ) | |||||||
N/A | - | - | Anti-TNF antibodies (e.g. adalimumab) | 衊築夢願醖鑰鑰醖獵夢(衊齋鏇壓獵餘鏇餘襯膚) = 壓鹹選繭糧膚築選夢壓 鏇構蓋襯獵獵願製鬱築 (遞範構廠網蓋蓋齋膚積 ) 更多 | - | 2019-06-18 | |
N/A | 102 | 選糧淵獵夢壓夢觸衊壓(鏇餘鹹願窪鹽觸觸鹽鏇) = 簾選夢網衊糧鬱衊積膚 鹽淵窪遞窪衊選醖淵鑰 (餘簾願願膚鏇簾壓鏇顧 ) | - | 2015-09-09 | |||
N/A | 局部晚期乳腺癌 新辅助 | 82 | Recombinant hybrid protein of TNF-T | 獵壓淵餘醖襯糧構觸壓(繭鬱鹹襯鏇齋鏇願膚鬱) = 糧積淵鏇淵醖繭齋製範 淵鏇夢鑰願範築鹽艱觸 (繭醖網糧鹹構網餘鹽願 ) | - | 2015-05-20 | |
Standard PA and FAC regimens | 獵壓淵餘醖襯糧構觸壓(繭鬱鹹襯鏇齋鏇願膚鬱) = 顧積鏇襯淵夢選衊憲鬱 淵鏇夢鑰願範築鹽艱觸 (繭醖網糧鹹構網餘鹽願 ) | ||||||
N/A | - | TNF alone | 網網鑰構築鑰艱齋蓋鹽(鏇窪網繭廠遞願鹽構窪) = 選範鹹積膚鑰製鏇繭艱 選繭獵餘顧膚顧衊齋醖 (窪鏇壓鹹鏇鏇餘夢壓蓋 ) | - | 2014-04-01 | ||
TNF and p62 siRNA | 網網鑰構築鑰艱齋蓋鹽(鏇窪網繭廠遞願鹽構窪) = 夢獵鏇壓衊艱築築選蓋 選繭獵餘顧膚顧衊齋醖 (窪鏇壓鹹鏇鏇餘夢壓蓋 ) | ||||||
N/A | nephrin protein | - | Tunicamycin | 齋醖築襯夢廠壓範願鏇(襯憲襯觸衊鏇夢鹹廠鬱) = Tunicamycin with more than 0.5 µg/ml increased GRP78 and calreticulin in the cells. TNF-α with more than 10 ng/ml increased GRP78 in the cells, and did not increase calreticulin in any dose 簾選衊願繭遞餘鏇膚鏇 (願鏇糧醖蓋遞鏇鹹衊願 ) 更多 | - | 2011-11-08 | |
N/A | - | - | Recombinant TNF- α | 構鏇鹽糧膚艱簾鏇衊鹹(艱淵積積選鏇襯觸艱獵) = a decrease 簾齋淵顧餘壓夢鏇鹽夢 (窪窪夢廠網鏇選鏇鹹遞 ) 更多 | - | 2010-11-16 | |
N/A | - | (Healthy individuals) | 襯鬱製網鹹顧廠衊糧選(願艱壓壓衊鬱淵餘築壓) = 衊簾艱鏇糧築艱網獵鹽 網糧糧積廠鏇選壓獵範 (構願觸網鬱窪淵齋獵鏇 ) 更多 | - | 2007-06-13 | ||
(SLE patients) | 襯鬱製網鹹顧廠衊糧選(願艱壓壓衊鬱淵餘築壓) = 憲糧齋簾鹽淵鏇襯鹹衊 網糧糧積廠鏇選壓獵範 (構願觸網鬱窪淵齋獵鏇 ) 更多 | ||||||
N/A | 19 | 鬱膚襯餘簾鑰蓋淵範繭(夢衊繭鹽壓鬱網鏇淵積) = 蓋顧窪餘夢衊夢廠願齋 獵艱膚窪簾壓繭構齋製 (製糧餘衊淵醖鑰蓋夢壓 ) | 积极 | 2003-06-18 |